Free Trial

STRATA Skin Sciences Q1 2023 Earnings Report

STRATA Skin Sciences logo
$3.00 -0.04 (-1.32%)
(As of 05:27 PM ET)

STRATA Skin Sciences Earnings Headlines

Strata Skin Sciences Outlines Growth and Profitability Plans
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
See More STRATA Skin Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like STRATA Skin Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on STRATA Skin Sciences and other key companies, straight to your email.

About STRATA Skin Sciences

STRATA Skin Sciences (NASDAQ:SSKN), a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

View STRATA Skin Sciences Profile

More Earnings Resources from MarketBeat

Upcoming Earnings